Baker Bros. Advisors LP Catalyst Pharmaceuticals, Inc. Transaction History

Baker Bros. Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $1.41 Million - $1.82 Million	-474,400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $76,032 - $130,048	-25,600 Reduced 5.12%	474,400 $1.41 Million
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $1.95 Million - $2.83 Million	-560,714 Reduced 52.86%	500,000 $2.31 Million
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $733,900 - $1.46 Million	-281,188 Reduced 20.95%	1,060,714 $4.08 Million
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $4.74 Million - $9.05 Million	-1,217,559 Reduced 47.57%	1,341,902 $7.13 Million
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $919,455 - $2.08 Million	-340,539 Reduced 11.74%	2,559,461 $9.83 Million
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $2.03 Million - $2.73 Million	-721,962 Reduced 19.93%	2,900,000 $11 Million
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $1.72 Million - $2.91 Million	-759,110 Reduced 17.33%	3,621,962 $11.3 Million
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $3.52 Million - $5.9 Million	-1,471,081 Reduced 25.14%	4,381,072 $10.5 Million
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $1.88 Million - $3.3 Million	750,000 Added 14.7%	5,852,153 $22.9 Million
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $12.2 Million - $15 Million	5,102,153	5,102,153 $12.9 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.